Literature DB >> 4551961

Clinical reactivity and immunogenicity of hemagglutinin influenza vaccine. I. Clinical reactions, hemagglutination-inhibiting and strain and type-specific complement-fixing antibody responses in subjects aged 3-6, 16-17 and 27-50 years.

H Závadová, V Vonka, E Adam, E Domorázková, F M Davenport.   

Abstract

Mesh：

Substances：

Year:  1972        PMID： 4551961

Source DB:  PubMed          Journal:  Arch Gesamte Virusforsch        ISSN： 0003-9012


× No keyword cloud information.
  15 in total

1.  COMPARISONS OF SEROLOGIC AND FEBRILE RESPONSES IN HUMANS TO VACCINATION WITH INFLUENZA A VIRUSES OR THEIR HEMAGGLUTININS.

Authors:  F M DAVENPORT; A V HENNESSY; F M BRANDON; R G WEBSTER; C D BARRETT; G O LEASE
Journal:  J Lab Clin Med       Date:  1964-01

2.  A METHOD FOR INCREASING THE SENSITIVITY OF THE HEMAGGLUTINATION-INHIBITION TEST WITH EQUINE INFLUENZA VIRUS.

Authors:  B S BERLIN; J L MCQUEEN; E MINUSE; F M DAVENPORT
Journal:  Virology       Date:  1963-12       Impact factor: 3.616

3.  PLAQUE TECHNIQUE WITH AN INFLUENZA A-2 VIRUS IN RUBBER STOPPERED BOTTLE CULTURES FROM MONKEY KIDNEY CELLS.

Authors:  V VONKA
Journal:  Arch Gesamte Virusforsch       Date:  1965

4.  Comparison of genetic properties of influenza viruses before and after repeated passages in monkey kidney cell culture.

Authors:  E Tucková; V Vonka; M Stárek
Journal:  Acta Virol       Date:  1968-07       Impact factor: 1.162

5.  Complete and abortive infection of cell cultures by influenza A2 virus.

Authors:  H Závadová; V Vonka; L Kutinová; E Tucková
Journal:  J Gen Virol       Date:  1968-05       Impact factor: 3.891

6.  Release of neuraminidase from hemagglutinins caused by treatment of influenza viruses with ether. (Brief report).

Authors:  A R Neurath; B A Rubin; R W Hartzell
Journal:  Arch Gesamte Virusforsch       Date:  1969

7.  A common surface antigen in influenza viruses from human and avian sources.

Authors:  R G Webster; H G Pereira
Journal:  J Gen Virol       Date:  1968-09       Impact factor: 3.891

8.  Respiratory virus vaccines. 3. Some biological properties of Sephadex-purified ether-extracted influenza virus antigens.

Authors:  F B Brandon; F Cox; G O Lease; E A Timm; E Quinn; I W McLean
Journal:  J Immunol       Date:  1967-04       Impact factor: 5.422

9.  Identification in a recombinant influenza virus of structural proteins derived from both parents.

Authors:  W G Laver; E D Kilbourne
Journal:  Virology       Date:  1966-11       Impact factor: 3.616

10.  STUDIES ON THE COMPLEMENT FIXATION ANTIGENS OF INFLUENZA VIRUSES TYPES A AND B.

Authors:  M Wiener; W Henle; G Henle
Journal:  J Exp Med       Date:  1946-03-31       Impact factor: 14.307
View more
  4 in total

1.  A new surface-antigen-adsorbed influenza virus vaccine. II. Studies in a volunteer group.

Authors:  C W Potter; R Jennings; C McLaren; D Edey; C H Stuart-Harris; M Brady
Journal:  J Hyg (Lond)       Date:  1975-12

2.  Clinical reactivity and immunogenicity of hemagglutinin influenza vaccine. II. Clinical reactions, hemagglutination-inhibitiong and strain and type-specific complement-fixing antibody responses in infants.

Authors:  H Závadová; E Adam; V Vonka; E Domorázková; M Kratochvílová; V Burian; F M Davenport
Journal:  Arch Gesamte Virusforsch       Date:  1972

3.  Immunological potency of a subunit influenza vaccine in adults.

Authors:  V Janout; M Uvizl
Journal:  Arch Virol       Date:  1977       Impact factor: 2.574

4.  Humoral and secretory antibody responses to immunization with low and high dosage split influenza virus vaccine.

Authors:  F L Ruben; C W Potter; C H Stuart-Harris
Journal:  Arch Virol       Date:  1975       Impact factor: 2.574
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.